DRW Securities’s Albany Molecular Research Inc AMRI Stock Holding History

DRW Securities’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-20,000	Closed	-$326K	–	162
2014 Q4	$326K	Buy	+20,000	New	+$367K	0.04%	85
2014 Q3	–	Sell	-210,000	Closed	-$4.22M	–	152
2014 Q2	$4.22M	Buy	+210,000	New	+$3.56M	0.77%	21

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

DRW Securities's AMRI Position: Q1 2015 in Review

DRW Securities sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 20,000 shares — an estimated $326K sold.

DRW Securities first reported a position in AMRI in Q2 2014 and held it in 2 quarters. The position peaked at $4.22M in Q2 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

DRW Securities reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
DRW Securities sold 20,000 Albany Molecular Research Inc shares in Q1 2015, an estimated $326K.
DRW Securities first reported a position in Albany Molecular Research Inc in Q2 2014 and held it in 2 quarters.
DRW Securities's Albany Molecular Research Inc position peaked at $4.22M in Q2 2014.
131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on DRW Securities's 13F filing for Q1 2015, filed 15 May 2015.